Table 4.
Clinical parameters according to different genotypes in CVA and control subjects
| Characteristics | CVA | Controls | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| CC (n = 10) | CG + GG (n = 17) | P value | CC (n = 138) | CG + GG (n = 94) | P value | |
| Age (years) | 46.89 ± 11.94 | 46.73 ± 11.85 | 0.9733 | 51.68 ± 14.52 | 50.91 ± 13.66 | 0.6851 |
| Gender (% male) | 50.00 | 52.94 | 0.8826 | 62.32 | 60.64 | 0.7961 |
| SBP (mmHg) | 113.17 ± 21.02 | 120.97 ± 23.13 | 0.8788 | 122.25 ± 23.61 | 125.24 ± 23.80 | 0.3462 |
| DBP (mmHg) | 74.82 ± 9.25 | 75.79 ± 10.01 | 0.6609 | 78.91 ± 10.23 | 80.39 ± 10.52 | 0.2860 |
| BMI (Kg/m2) | 23.48 ± 1.61 | 23.50 ± 1.67 | 0.4945 | 23.16 ± 1.67 | 23.08 ± 1.42 | 0.7042 |
| LVEF (%) | 59.83 ± 6.49 | 60.29 ± 6.64 | 0.5008 | 62.34 ± 6.81 | 62.44 ± 6.89 | 0.9131 |
| TC (mmol/L) | 4.94 ± 0.66 | 5.11 ± 0.74 | 0.0979 | 4.82 ± 0.53 | 4.93 ± 0.62 | 0.1490 |
| LDL-C (mmol/L) | 2.55 ± 0.81 | 2.68 ± 0.90 | 0.0722 | 2.56 ± 0.51 | 2.51 ± 0.46 | 0.4466 |
| HDL-C (mmol/L) | 1.43 ± 0.26 | 1.38 ± 0.25 | 0.3028 | 1.43 ± 0.29 | 1.50 ± 0.33 | 0.0893 |
| TG (mmol/L) | 1.63 ± 0.58 | 1.53 ± 0.51 | 0.3219 | 1.63 ± 0.58 | 1.70 ± 0.69 | 0.4045 |
| IL-6 (pg/ml) | 2.68 ± 0.73 | 3.47 ± 0.93 | 0.0303 | 2.57 ± 0.64 | 2.78 ± 0.76 | 0.0240 |